|
|
Title: Method for identifying
Listeria monocytogenes and culture medium
United States Patent: 7,270,978
Issued: September 18, 2007
Inventors: Roger-Dalbert;
Ce (Vaux en Buggey, FR), Barbaux; Laurence (Amberieu-en-Bugey, FR)
Assignee: Biomerieux S.A.
(Marcy l'Etoile, FR)
Appl. No.: 10/432,048
Filed: November 19, 2001
PCT Filed: November 19,
2001
PCT No.: PCT/FR01/03627
371(c)(1),(2),(4) Date: May
18, 2003
PCT Pub. No.: WO02/40705
PCT Pub. Date: May 23, 2002
|
|
|
Covidien Pharmaceuticals Outsourcing
|
Abstract
A substrate which can be used for the
direct identification of pathogenic bacteria belonging to the genus
Listeria by detecting an esterase activity other than Phosphatidyl
Inositol-specific Phospholipase C (PI-PLC), an esterase which is specific
to the species Listeria monocytogenes. The use of two substrates, one as
described above and the other specific for all or some members of the
genus Listeria, and a reaction medium containing such a substrate or such
a combination of substrates are disclosed. An identification method which
exploits such culture media is also disclosed. The invention is
particularly applicable in the field of diagnosis.
Description of the Invention
This application is a U.S. National Stage
of International Application PCT/FR01/03627, filed Nov. 19, 2001 and
published on May 23, 2002 in the French Language.
This invention concerns a chromogenic substrate which can be used for the
direct identification of pathogenic bacteria belonging to the genus
Listeri, more precisely those of the species Listeria monocytogenes.
The invention also concerns using a combination of two substrates, one
substantially specific for the species Listeria monocytogenes, and the
other either specific or not for the genus Listeria. It also concerns a
reaction medium containing such a substrate or such a combination of
substrates. Finally, it concerns an identification method exploiting such
culture media.
For many years, special substrates have been used to determine whether
certain enzyme activities typical of microorganisms are present or not.
Through the use of specific substrates, it is possible--on the basis of
whether a reaction takes place or not--to characterize the nature of a
group of microorganisms, or distinguish between different strains and/or
species belonging to a given genus.
Synthetic enzyme substrates such as those exploited in this invention are
made up of two different parts: the first part is specific to the enzyme
activity being tested for and will hereafter be referred to as the target
part; the second part acts as a marker and will hereafter be referred to
as the marker part.
Such special substrates may be either fluorescent or chromogenic. In fact,
the second marker part or the product of its reaction with one or more
other compounds becomes fluorescent or chromogenic when it is no longer
bound to the first target part (in this context, refer to Patent
Application PCT/FR99/00781 filed on behalf of the applicant).
Isolating and identifying the bacterium Listeria monocytogenes is a major
problem in safety monitoring in both the food industry and medical
bacteriology. Among all the bacterial species belonging to the genus
Listeria, only Listeria monocytogenes is known to be pathogenic in humans.
It can cause listeriosis, a condition which is sometimes mortal (in 25 to
35% of cases) in the immunodeficient, very young children and pregnant
women. Other Listeria species are non-pathogenic, or are only pathogenic
in animals. Such is the case in particular for Listeria ivanovii.
Although the danger of listeriosis has diminished in recent years in most
developed countries, modern society demands ever more stringent safety
and, even if sporadic cases are accepted, more widespread outbreaks are
not.
However, in France, for example, risk management policy tends to focus on
the products further down the line (e.g. contamination levels in finished
products) rather than components higher up in the production process (the
infection of livestock). As a result, between 15 and 60% of all poultry
carcasses, between 3 and 36% of all pig carcasses, and between 7 and 28%
of all cow carcasses are contaminated by Listeria.
Therefore, when it comes to human bacterial infection, it is important to
be able to make a definitive distinction between Listeria monocytogenes
and the other, non-pathogenic members of the genus Listeria.
Distinction has traditionally been made between different Listeria spp. by
using selective culture media. Two particular selective media are in the
most widespread use: Palcam (Van Netten et al., J. Food Microbiol. (1988),
6, pp. 187-188) and Oxford (Curtis et al., Lett. Appl. Microbiol. (1989),
8, pp. 85-98). All species belonging to the genus Listeria can be detected
using these media. Typical colonies are obtained which must subsequently
be identified by means of further tests--microscopic and/or biochemical
and/or immunologic and/or genetic--to check whether or not the colony
corresponds to the species Listeria monocytogenes.
These extra experiments both slow down and increase the cost of testing.
Furthermore, they require many different reagents and necessitate trained
technicians. Finally, since picking the colonies to be identified is a
random process, the extra experiments often introduce mistakes, or at
least compromise the accuracy and reliability of the result. This is a
particularly acute problem when the number of colonies of Listeria
monocytogenes on the isolation medium is much lower than the number of
colonies of other Listeria species.
The Applicant's Patent EP-B-0.496.680 describes a bacteriological test
method to differentiate the species Listeria monocytogenes from other
bacterial species which belong to the genus Listeria. According to this
method, use is made of an identification medium containing a chromogenic
or fluorogenic substrate which is hydrolyzed by an enzyme called Glycine
aminopeptidase. The medium used may also contain a substrate which can be
fermented and/or a substrate which can be reduced and/or a substrate which
can be enzymatically hydrolyzed, such as the substrate for .alpha.-mannosidase,
the chemical conversion of which makes it possible to characterize the
Listeria species present in the test sample.
This useful approach has one major drawback in that the species Listeria
monocytogenes is the only one not to express Glycine aminopeptidase
activity. It is therefore possible to identify all Listeria species except
the one member of the genus which is pathogenic, namely Listeria
monocytogenes. Trying to detect Listeria monocytogenes by virtue of the
absence of a certain activity is not very reliable since such a negative
test lacks specificity because of the possibility of mutation and because
another species might not be expressing its normal pattern of activity due
to stress.
Methods based on using chromogenic media to detect Listeria genus-specific
.beta.-glucosidase activity have been developed. Moreover, other
techniques based on chromogenic media can be used to distinguish between
Listeria monocytogenes and Listeria ivanovii from other Listeria species
by assaying phosphatidylinositol phospholipase C (PI-PLC) activity.
It has been shown that certain species of the genus Listeria (such as
Listeria monocytogenes and Listeria ivanovii) secrete PI-PLC into the
culture medium (Leimeister-Wachter et al., Mol. Microbiol. (1991) 5(2),
pp. 361-366; J. Mengaud et al., Mol. Microbiol. (1991) 5(2), pp. 367-372;
and Goldfine et al., Infection and Immunity (1992) 60(10), pp. 4059-4067).
It is also known that these two species can be identified using indirect
methods (Notermans et al., App. and Env. Microbiology (1991), vol. 57
n.degree.9, pp. 2666-2670.
Patent Application WO-A-99/04032 describes a culture medium containing a
chromogenic substrate which is specific for Listeria monocytogenes and
Listeria ivanovii, in the form of a phosphatidylinositol derivative such
as the ammonium salt of
5-Bromo-4-chloro-3-indolyl-myo-inositol-1-phosphate. This affords direct
detection of both these species in a single step, and therefore makes it
possible to distinguish these two from all other Listeria species.
Bacteriological detection tests based on PI-PLC are also dealt with in the
following documents: WO-A-98/38332 which focuses on a method and a
detection test for PI-PLC, based on the cleavage of a substrate by the
enzyme, one of the residues of said substrate being chromogenic and making
it possible to identify pathogenic Listeria, and WO99/48899 which
describes a fluorogenic substrate based on 4-methylumbelliferone which is
used to detect the PI-PLC activity expressed by a number of different
species, namely Clostridium spp., Listeria ivanovii, Staphylococcus aureus,
Bacillus cereus, Bacillus thuringiensis as well as Listeria monocytogenes.
In this document, attention is drawn to the fact that phospholipase C
activity is not specific for Listeria monocytogenes since it is also found
in other species, including another Listeria species, namely Listeria
ivanovii.
However, it should be noted that esterase substrates are more easily and
more cheaply synthesized than substrates for PI-PLC. Moreover, the
advantage of using a chromogenic substrate (rather than a natural one) is
that visual detection is easier, i.e. it is easier to distinguish colored
colonies than it is to visualize a halo surrounding colonies. This
advantage furthermore applies to cultures containing different
microorganisms in that each colony has its own specific color, whereas a
halo could spread out below two disparate colonies.
The purpose of this invention is to offer a detection method which makes
it possible to differentiate the species Listeria monocytogenes from all
other Listeria species. This is achieved by detecting at least one
metabolic activity which has not hitherto been used either to detect
Listeria or to differentiate Listeria monocytogenes from other species
belonging to the genus Listeria. This activity is an esterase which is
expressed far more strongly by Listeria monocytogenes than by other
species in the genus. In addition, at least one other activity is assayed,
namely an activity which is expressed by all or some Listeria such as a
saccharidase, a phosphatase or an aminopeptidase, which enhances the
contrast between the color of colonies of Listeria monocytogenes and that
of colonies of other species belonging to the same genus. This makes it
possible to distinguish Listeria monocytogenes from Listeria ivanovii et
Listeria innocua, which are the species most commonly isolated, and which
have enzyme profiles closely resembling that of Listeria monocytogenes.
To this effect, this invention concerns a substrate which can be used to
directly identify pathogenic bacteria belonging to the genus Listeria,
characterized in that it detects a Listeria monocytogenes-specific
esterase activity, an esterase activity which is distinct from PI-PLC
activity.
Thus although PI-PLC is an esterase, Listeria ivanovii is esterase
negative despite being PI-PLC positive; therefore it could be confused
with Listeria monocytogenes. In contrast to the background art and methods
based on the detection of PI-PLC activity which do not differentiate
Listeria monocytogenes from other Listeria species, this invention makes
it possible to detect Listeria monocytogenes in a more specific way.
According to a preferred embodiment, the esterase activity is a specific
enzyme activity, i.e. it cleaves the ester linkage between the marker part
and the target part of the substrate.
According to a preferred embodiment, the linkage cleaved is an ester bond
between an alcohol group on the marker part and an organic acid which
constitutes the target.
According to a preferred embodiment, the marker part consists of a
chromogenic molecule such as indoxyl which could be constituted by one of
the following constituents: 5-Bromo-3-indoxyl, or
5-Bromo-4-chloro-3-indoxyl, or 6-Chloro-3-indoxyl, or
5-Bromo-6-chloro-3-indoxyl, or 6-Bromo-3-indoxyl.
According to a preferred embodiment, the target part consists of a fatty
acid with a carbon chain containing between 2 and 20 carbon atoms,
preferably between 4 and 10 carbon atoms.
Preferably, the substrate is either 5-Bromo-4-chloro-3-indolyl butyrate,
5-Bromo-4-chloro-3-indolyl octanoate, 5-Bromo-4-chloro-3-indolyl nonanoate
or 5-Bromo-4-chloro-3-indolyl decanoate.
According to a modified embodiment, the substrate is paired with at least
one other substrate making it possible to detect at least one other enzyme
activity expressed by all or some Listeria species.
In the case in which there are two substrates, the substrate to detect
esterase activity other than PI-PLC gives a color which is different from
that given by the other enzyme activity which is different from the
above-mentioned esterase activity.
According to a preferred embodiment, the other enzyme activity expressed
by all or some Listeria species is a saccharidase, a phosphatase or an
aminopeptidase.
Preferably, the marker part of the other substrate is based on:
5-Bromo-3-indoxyl, or 5-Bromo-4-chloro-3-indoxyl, or 6-Chloro-3-indoxyl,
or 5-Bromo-6-chloro-3-indoxyl, or 6-Bromo-3-indoxyl. With respect to
-Chloro-3-indoxyl, such a molecule is particularly well described in
Patent U.S. Pat. No. 5,364,767 in which it is essentially associated withN-Acetyl-.beta.-D-galactosaminide,
with N-Acetyl-.beta.-D-glucosaminide, with Butyrate, with Octanoate, with
the salt of p-toluidine phosphate, with Sulfate or with .beta.-D-Glucopyranoside.
It can also be based on 5-Bromo-6-chloro-3-indoxyl.
According to a modified embodiment, the other substrate consists of:
5-Bromo-6-chloro-3-indolyl-.beta.-D-glucoside, or
6-Chloro-3-indolyl-.beta.-D-glucoside, or 6-Chloro-3-indolyl-.beta.-D-cellobioside,
or 6-Chloro-3-indolyl-N-acetyl-.beta.-D-glucosaminide, or
6-Chloro-3-indolyl-.alpha.-D-mannoside, or 6-Chloro-3-indolylphosphate.
This invention also concerns a reaction medium which allows the direct
identification of Listeria monocytogenes, which exploits one or two
substrates as defined above.
More precisely, the substrate which detects the esterase activity other
than PI-PLC is at a concentration of between 20 mg/l and 3 g/l, or
preferably between 50 mgL and 1 g/l, or preferably between 100 and 600
mg/l, or about 250 mg/l.
More precisely, the substrate which detects the other activity such as a
saccharidase, a phosphatase or an aminopeptidase is at a concentration of
between 10 mg/l and 500 mg/l, preferably between 50 and 300 mg/l, and more
preferably still between 100 and 200 mg/l.
The medium is either liquid or semi-solid (with agar).
According to a modified embodiment, the medium includes a means of
distinguishing Listeria monocytogenes from Listeria welshimeri and
Listeria seeligeri, namely: the addition of at least one acidified
carbohydrate (e.g. Xylose and/or D-Tagatose) by Listeria welshimeri and
Listeria seeligeri and not by Listeria monocytogenes, or the addition of
at least one acidified carbohydrate by Listeria monocytogenes and possibly
Listeria innocua and/or Listeria ivanovii and/or Listeria grayii. the
addition of at least one substrate to detect saccharidase activity
(.beta.-maltosidase) and/or phosphatase and/or aminopeptidase activity (L-glycine
aminopeptidase) specific at least to Listeria welshimeri and Listeria
seeligeri but not Listeria monocytogenes, or the addition of a natural
Phospholipase (PLC) substrate, such as Phosphatidylinositol (PI) and/or
Phosphatidylcholine (PC).
According to a particular embodiment, the medium includes a selective
means of differentiating Listeria monocytogenes from at least the
following species: Staphylococcus aureus, Bacillus thuringiensis,
Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, and
Candida albicans.
According to a preferred embodiment, the selective means is constituted by
one of the following compounds: Lithium chloride Ceftazidime, Amphotericin
B, Fosfomycin, and/or Colistin.
This invention furthermore concerns a method for identifying pathogenic
bacteria belonging to the species Listeria monocytogenes, comprising the
following steps: seeding of a culture medium as described above with a
specimen suspected of containing the pathogenic bacteria, incubation of
the culture medium seeded with the specimen, and determination of the
presence of said pathogenic bacteria by virtue of the color and intensity
typical of the substrate(s).
According to a modified embodiment, said specimen suspected of containing
pathogenic bacteria is preliminarily concentrated prior to seeding on the
culture medium, as defined above.
According to another modified embodiment of the method, whether or not
said pathogenic bacteria are present is determined by virtue of the color
and intensity typical of the substrate(s) after a period of 18 to 24 hours
of incubation.
Finally, the invention proposes using a substrate consisting of a target
part as defined above and an inhibitory part which specifically inhibits
Listeria monocytogenes when it is released.
This invention therefore essentially concerns the differentiation of
Listeria monocytogenes from other species belonging to the genus Listeria.
Esterase enzyme activity is a good marker for differentiating the species
Listeria monocytogenes from other species belonging to the genus Listeria,
apart from the more specific esterase activity referred to as PI-PLC.
Thus, the background art described above demonstrates the lack of
specificity of PI-PLC (which is specific for a certain type of lipid)
vis-a-vis differentiating the species Listeria monocytogenes and Listeria
ivanovii, for example. PI-PLC hydrolyzes Phosphatidylinositol derivatives
at a point between the Glycerol and the inorganic Phosphate. In the case
of a chromogenic substrate, the enzyme cleaves between the marker part and
the inorganic Phosphate bound to the Inositol, as illustrated below (see Original Patent).
Esterases according to this invention hydrolyze lipids containing one or
more fatty acids with a chain preferably containing between 7 and 10
carbon atoms. These esterases hydrolyze ester bonds between an alcohol and
an organic fatty acid, as illustrated below (see Original Patent).
Claim 1 of 13 Claims
1. A composition for the
direct identification of pathogenic bacteria belonging to the species
Listeria monocytogenes, said composition comprising a first substrate
comprising a target part comprising a fatty acid having a carbon chain
containing between 2 and 20 carbon atoms and a marker part, and wherein said
first substrate is cleavable by an esterase activity other than Phosphatidyl
Inositol-specific Phospholipase C (PI-PLC), and wherein said esterase
activity is specific for Listeria monocytogenes and not specific for other
members of the genus Listeria further comprising a second substrate
comprising a target part and a marker part, wherein said second substrate
detects at least one other enzyme activity expressed by all or some Listeria
species, and wherein the marker part of said first substrate is different
from the marker part of said second substrate.
____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|